Detalles de la búsqueda
1.
Bone-modifying agents are protective for symptomatic skeletal events in Radium-223 treatment.
Int J Urol
; 30(11): 1029-1034, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37501328
2.
Effectiveness and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastases in real-world practice: A multi-institutional study.
Int J Urol
; 30(2): 139-146, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305673
3.
Dissociated response among multiple metastatic lesions in the patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
Jpn J Clin Oncol
; 52(12): 1430-1435, 2022 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36093731
4.
Short-term and long-term outcomes of indigo naturalis treatment for inflammatory bowel disease.
J Gastroenterol Hepatol
; 35(3): 412-417, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31389626
5.
Predictive factors of late biochemical recurrence after radical prostatectomy.
Jpn J Clin Oncol
; 47(3): 233-238, 2017 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27940489
6.
Type IV Gastric Carcinoids in the Stomach Caused by ATP4A Gene Mutations.
Clin Gastroenterol Hepatol
; 18(10): A22, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31401365
7.
Is autofluorescence imaging useful for the diagnosis of dysplasia in ulcerative colitis?
Dig Endosc
; 31 Suppl 1: 45-46, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30994224
8.
Change in the Neutrophil-to-Eosinophil Ratio After Avelumab Maintenance for Advanced Urothelial Carcinoma: The UROKYU Study.
Anticancer Res
; 44(4): 1675-1681, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38537962
9.
Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multicenter Retrospective Study.
Curr Oncol
; 31(2): 862-871, 2024 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38392058
10.
Organ-specific Tumor Response to Avelumab Maintenance Therapy for Advanced Urothelial Carcinoma: A Multicenter Retrospective Study.
Anticancer Res
; 43(12): 5689-5698, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38030199
11.
Early Phase Persistent Changes in the White Blood Cell Fraction in Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab: A Multicenter Retrospective Study.
Anticancer Res
; 43(10): 4701-4708, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37772560
12.
Diffuse gastric metastases from salivary duct carcinoma.
Gastrointest Endosc
; 86(5): 916-917, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28576393
13.
Optimal Timing of Switching from Platinum-based Chemotherapy to Pembrolizumab for Advanced Urothelial Carcinoma Based on Real-world Data: A Multi-institutional Retrospective Study.
Anticancer Res
; 42(3): 1571-1577, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35220254
14.
Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab.
Cancer Manag Res
; 14: 1641-1651, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35535266
15.
Efficacy of Pembrolizumab in Patients With Variant Urothelial Carcinoma: A Multicenter Retrospective Study.
Clin Genitourin Cancer
; 20(5): 499.e1-499.e8, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35624001
16.
Lymphoid and myeloid proliferative disorders associated with inflammatory bowel disease: a clinicopathological study of 15 cases.
Hum Pathol
; 120: 88-98, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34990621
17.
The Eosinophil Changes, Efficacy and Safety of Pembrolizumab in Advanced Urothelial Carcinoma Patients with an Older Age and a Poor Performance Status.
Onco Targets Ther
; 15: 1321-1330, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36388155
18.
Paclitaxel and carboplatin chemotherapy after platinum-based chemotherapy and pembrolizumab for metastatic urothelial carcinoma.
Mol Clin Oncol
; 14(5): 91, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33767860
19.
Clinical Outcomes of Mixed Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy.
In Vivo
; 35(5): 2869-2874, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34410980
20.
The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab.
Cancer Manag Res
; 13: 8049-8056, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34729023